Metabolites in Safety Testing Assessment in Early Clinical Development: A Case Study With a Glucokinase Activator

Drug Metabolism and Disposition- United States

doi 10.1124/dmd.114.060087

Full Text

Abstract

Available in

Date

Authors

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)


Related search